Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Natasha van't Boveneind-Vrubleuskaya"'
Autor:
Ivan S. Pradipta, Natasha van’t Boveneind-Vrubleuskaya, Onno W. Akkerman, Jan-Willem C. Alffenaar, Eelko Hak
Publikováno v:
Antimicrobial Resistance and Infection Control, Vol 8, Iss 1, Pp 1-12 (2019)
Abstract Background Since in low incidence TB countries population migration and complex treatment of drug-resistant tuberculosis (DR-TB) patients are major issues, we aimed to analyse patient risk factors associated with the incidence of poor outcom
Externí odkaz:
https://doaj.org/article/d0e08e6446cb43b38397f3a6b9301954
Autor:
Natasha Van't Boveneind-Vrubleuskaya, Alper Daskapan, Jos G W Kosterink, Tjip S van der Werf, Susan van den Hof, Jan-Willem C Alffenaar
Publikováno v:
PLoS ONE, Vol 11, Iss 11, p e0166030 (2016)
Standard treatment duration for drug-susceptible tuberculosis (TB) treatment is 6 months. Treatment duration is often extended-and for various different reasons. The aim of this study was to determine the prevalence and to assess risk factors associa
Externí odkaz:
https://doaj.org/article/18d7954d8481439c8c0f00ab980ae217
Autor:
Ruben van der Galiën, Alena Skrahina, Charles A. Peloquin, Jan-Willem C. Alffenaar, Daan J Touw, Natasha van't Boveneind-Vrubleuskaya
Publikováno v:
Clinical Pharmacokinetics, 59(7), 899-910. Springer International Publishing AG
BACKGROUND AND OBJECTIVE: Multidrug-resistant tuberculosis has much poorer treatment outcomes compared with drug-susceptible tuberculosis because second-line drugs for treating multidrug resistant tuberculosis are less effective and are frequently as
Autor:
Jan-Willem C. Alffenaar, Ivan S. Pradipta, Natasha van't Boveneind-Vrubleuskaya, Onno W. Akkerman, Eelko Hak
Publikováno v:
Antimicrobial Resistance and Infection Control, Vol 8, Iss 1, Pp 1-12 (2019)
Antimicrobial Resistance and Infection Control
Antimicrobial Resistance and Infection Control, 8:115. BioMed Central Ltd.
Antimicrobial Resistance and Infection Control
Antimicrobial Resistance and Infection Control, 8:115. BioMed Central Ltd.
Background Since in low incidence TB countries population migration and complex treatment of drug-resistant tuberculosis (DR-TB) patients are major issues, we aimed to analyse patient risk factors associated with the incidence of poor outcome of TB t
Autor:
Natasha van't Boveneind-Vrubleuskaya, Fajri Gafar, Onno W. Akkerman, Jan-Willem C. Alffenaar, Bob Wilffert
Publikováno v:
European Respiratory Journal, 54(4):1901402. EUROPEAN RESPIRATORY SOC JOURNALS LTD
BackgroundAs a vulnerable population, children and adolescents with tuberculosis (TB) are faced with many challenges, even those who live in low TB incidence countries. We aimed to evaluate factors associated with TB treatment outcomes allowing more
Autor:
Simone H J van den Elsen, Charles A. Peloquin, Alena Skrahina, Giovanni Battista Migliori, Daan J Touw, Stellah G. Mpagama, Scott K. Heysell, Marieke G G Sturkenboom, Tjip S. van der Werf, Natasha van't Boveneind-Vrubleuskaya, Jan-Willem C. Alffenaar
Publikováno v:
Antimicrobial Agents and Chemotherapy, 62(12):ARTN e01092-18. AMER SOC MICROBIOLOGY
Levofloxacin is an antituberculosis drug with substantial interindividual pharmacokinetic variability; therapeutic drug monitoring (TDM) could therefore be helpful to improve treatment results. TDM would be more feasible with limited sampling strateg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0130faf5f0641eb5798f61f1a81edace
https://research.rug.nl/en/publications/71e26eae-69ad-4049-aa9b-4864bc92a36b
https://research.rug.nl/en/publications/71e26eae-69ad-4049-aa9b-4864bc92a36b
Autor:
Onno W. Akkerman, Jan-Willem C. Alffenaar, Fajri Gafar, Natasha van't Boveneind-Vrubleuskaya, Taichi Ochi, Bob Wilffert, Susan van den Hof, Tjip S. van der Werf, Connie Erkens
Publikováno v:
European Respiratory Journal, 56(4):2001086. EUROPEAN RESPIRATORY SOC JOURNALS LTD
BackgroundTuberculosis (TB) in children and adolescents is a sentinel event for ongoing transmission. In the Netherlands, epidemiological characteristics of childhood and adolescent TB have not been fully evaluated. Therefore, we aimed to assess TB e
Autor:
Alena Skrahina, Jan-Willem C. Alffenaar, Jos G. W. Kosterink, Kai van Hateren, Dick van Soolingen, Tatiana Seuruk, Tjip S. van der Werf, Natasha van't Boveneind-Vrubleuskaya, Tridia van der Laan, Susan van den Hof
Publikováno v:
Antimicrobial Agents and Chemotherapy, 61, 8, pp. e00343-17e00343-17-e00343-17
Antimicrobial agents and chemotherapy, 61(8):e00343-17. American Society for Microbiology
Antimicrobial Agents and Chemotherapy, 61, e00343-17e00343-17-e00343-17
Antimicrobial Agents and Chemotherapy, 61(8):ARTN e00343-17. AMER SOC MICROBIOLOGY
Antimicrobial agents and chemotherapy, 61(8):e00343-17. American Society for Microbiology
Antimicrobial Agents and Chemotherapy, 61, e00343-17e00343-17-e00343-17
Antimicrobial Agents and Chemotherapy, 61(8):ARTN e00343-17. AMER SOC MICROBIOLOGY
Pharmacodynamics are especially important in the treatment of multidrug- and extensively drug-resistant tuberculosis (M/XDR-TB). The free area under the concentration time curve in relation to MIC ( f AUC/MIC) is the most relevant pharmacokinetic (PK
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2270cdfa432e6627bb515599bd8be89b
https://hdl.handle.net/2066/177450
https://hdl.handle.net/2066/177450